• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Episode 1 - The Changing Tides of Multiple Sclerosis: Where Do We Currently Stand?

Video

In a discussion moderated by Dr. Fred Lublin, Drs. Patricia K Coyle, Leslie Fish, and Gary M. Owens share their insights and perspectives on the increasing prevalence and incidence of multiple sclerosis (MS) worldwide, despite great clinical strides in recent years. United States is recognized as a high-risk zone for developing MS, and although previous estimates suggested that the US was limited to approximately 400,000 cases of MS, new data indicates that the prevalence may actually be closer to 750,000. MS tends to strike individuals during their peak productive years, causes chronic disability, and is associated with heavy disease and economic burden. As such, it is vital to expand the discussion of managed care strategies while continuing the exploration for optimal therapeutic amidst an evolving drug pipeline for MS.


Related Videos
dr carol regueiro
dr carol regueiro
Screenshot of Adam Colborn, JD during an interview
dr carol regueiro
Wanmei Ou, PhD, vice president of product, data analytics, and AI at Ontada
Glenn Balasky, executive director of the Rocky Mountain Cancer Center.
Corey McEwen, PharmD, MS
dr linda bosserman
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.